Two soaring ASX small-cap shares are setting the bar high on Friday. The post 2 ASX small-cap shares rocketing 35% to 54% ...
Radiopharm Theranostics (ASX:RAD) has executed a subscription agreement for a private placement of ordinary shares to ...
RAD to advance the clinical development of Lantheus innovative radiopharmaceuticals in Australia Initial collaboration will focus on a Phase 1 imaging trialFinancial incentives to be paid to RAD upon ...
RAD to advance the clinical development of Lantheus innovative radiopharmaceuticals in Australia Initial collaboration will ...
Supply chain shifts, zero-emissions freight, and automated vehicles are among topics to be discussed at the 104 th annual meeting of the Transportation Research Board in Washington, D.C., next month.
A substantial insider activity was disclosed on December 24, as MARKISON, CEO at Lantheus Holdings LNTH, reported the exercise of a large sell of company stock options. What Happened: MARKISON ...
It is still unclear what led to the assassination of health insurance boss Brian Thompson Grievances with the healthcare industry is one key line of inquiry on account of the victim of the ...
In the interim, Lantheus Holdings’ CEO Brian Markison and President Paul Blanchfield will oversee the research and development responsibilities previously held by Dr. Humphrey. The company maintains ...
Lantheus has begun a search for his successor, it said. Chief Executive Brian Markison and President Paul Blanchfield are filling in as interim leaders of research and development.
In the interim, Lantheus Holdings' CEO Brian Markison and President Paul Blanchfield will oversee the research and development responsibilities previously held by Dr. Humphrey. The company ...